At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ways to deliver these treatments to as many people as possible.
Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, including important safety information.
If you have a medical condition, promptly see your physician or other healthcare provider.
Showing 96 results
ADAKVEO® (crizanlizumab-tmca)(injection, for intravenous use)
AFINITOR® DISPERZ (everolimus tablets for oral suspension)(tablets for oral suspension)
AFINITOR® (everolimus) tablets for oral administration(tablets for oral administration)
AIMOVIG® (erenumab-aooe)(injection, for subcutaneous use)
Alomide® (lodoxamide tromethamine ophthalmic solution) 0.1%(lodoxamide tromethamine ophthalmic solution)
Arzerra® (ofatumumab)(injection, for intravenous use)
Azopt® (brinzolamide ophthalmic suspension) 1%(brinzolamide ophthalmic suspension)Resources
Beovu® (brolucizumab-dbll)(injection, for intravitreal use)
Betoptic S® (betaxolol hydrochloride ophthalmic suspension) 0.25%(sterile topical ophthalmic drops)